These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 11982602)

  • 1. Immunophenotypic characterization of peripheral T lymphocytes in Mycobacterium tuberculosis infection and disease.
    Rodrigues DS; Medeiros EA; Weckx LY; Bonnez W; Salomão R; Kallas EG
    Clin Exp Immunol; 2002 Apr; 128(1):149-54. PubMed ID: 11982602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens.
    Benito JM; Zabay JM; Gil J; Bermejo M; Escudero A; Sánchez E; Fernández-Cruz E
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Feb; 14(2):128-35. PubMed ID: 9052721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different meaning of CD38 molecule expression on CD4+ and CD8+ cells of children perinatally infected with human immunodeficiency virus type 1 infection surviving longer than five years.
    de Martino M; Rossi ME; Azzari C; Gelli MG; Galli L; Vierucci A
    Pediatr Res; 1998 Jun; 43(6):752-8. PubMed ID: 9621984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.
    Resino S; Navarro J; Bellón JM; Gurbindo D; León JA; Muñoz-Fernández MA
    Clin Exp Immunol; 2001 Aug; 125(2):266-73. PubMed ID: 11529919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indicators of T-cell activation: correlation between quantitative CD38 expression and soluble CD8 levels in asymptomatic HIV+ individuals and healthy controls.
    Lenkei R; Bratt G; Holmberg V; Muirhead K; Sandström E
    Cytometry; 1998 Oct; 33(2):115-22. PubMed ID: 9773871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
    Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
    Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An imbalance of naive and memory/effector subsets and altered expression of CD38 on T lymphocytes in two girls with hyper-IgM syndrome.
    Costa-Carvalho BT; Viana MA; Brunialti MK; Kallas EG; Salomao R
    Clin Exp Immunol; 2004 May; 136(2):291-6. PubMed ID: 15086393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
    Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
    Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression.
    Liu Z; Cumberland WG; Hultin LE; Prince HE; Detels R; Giorgi JV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):83-92. PubMed ID: 9358102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic analysis of CD8+ T lymphocytes in a cohort of HIV type 1-infected patients treated with saquinavir, ritonavir, and two nucleoside analogs for 1 year, and association with plasma HIV type 1 RNA.
    Kaufmann GR; Zaunders JJ; Cunningham P; Cooper DA
    AIDS Res Hum Retroviruses; 1999 Jul; 15(11):963-72. PubMed ID: 10445808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children.
    Plaeger-Marshall S; Hultin P; Bertolli J; O'Rourke S; Kobayashi R; Kobayashi AL; Giorgi JV; Bryson Y; Stiehm ER
    J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):984-93. PubMed ID: 7688045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotyping of blood lymphocytes at birth, during childhood, and during adulthood in HIV-1-uninfected Ethiopians.
    Tsegaye A; Wolday D; Otto S; Petros B; Assefa T; Alebachew T; Hailu E; Adugna F; Measho W; Dorigo W; Fontanet AL; van Baarle D; Miedema F
    Clin Immunol; 2003 Dec; 109(3):338-46. PubMed ID: 14697749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential susceptibility of resting CD4(+) T lymphocytes to a T-tropic and a macrophage (M)-tropic human immunodeficiency virus type 1 is associated with their surface expression of CD38 molecules.
    Horikoshi H; Kinomoto M; Sasao F; Mukai T; Luftig RB; Ikuta K
    Virus Res; 2001 Jan; 73(1):1-16. PubMed ID: 11163640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ T cell subsets in aging.
    Ruiz M; Esparza B; Pérez C; Barranquero M; Sabino E; Merino F
    Immunol Invest; 1995 Nov; 24(6):891-5. PubMed ID: 8575835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of suppression of viral replication by highly active antiretroviral therapy on immune function and phenotype in chronic HIV-1 infection.
    Lange CG; Lederman MM; Madero JS; Medvik K; Asaad R; Pacheko C; Carranza C; Valdez H
    J Acquir Immune Defic Syndr; 2002 May; 30(1):33-40. PubMed ID: 12048361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotypic analysis of HIV-infected children: alterations within the first year of life, changes with disease progression, and longitudinal analyses of lymphocyte subsets.
    McCloskey TW; Kohn N; Lesser M; Bakshi S; Pahwa S
    Cytometry; 2001 Jun; 46(3):157-65. PubMed ID: 11449406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities. Swiss HIV Cohort Study.
    Bisset LR; Cone RW; Huber W; Battegay M; Vernazza PL; Weber R; Grob PJ; Opravil M
    AIDS; 1998 Nov; 12(16):2115-23. PubMed ID: 9833852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte subsets in human tonsils: the effect of age and infection.
    Rosenmann E; Rabinowitz R; Schlesinger M
    Pediatr Allergy Immunol; 1998 Aug; 9(3):161-7. PubMed ID: 9814732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.